We discovered that this was not the case, as anti-CD8α-treated and anti-NK1.1-treated enteric-glia-depleted mice exhibited reduced tumor burdens similar to that observed in the isotype-treated controls (Figures 2A, B). Here, CD8A is linked to neoplasm.